ArticleKidney medicine2022

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program.

Steven Fishbane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.